Delivery Order SPE2DB20D1109-SPE2DB24FP03A
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,990.36 Firm Fixed Price Delivery Order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,891.24 firm fixed-price delivery order is for the supply of 4,565,188,727 units of the KEDRAB 300 IU/2 ML vial product. The contract has an ultimate completion date of August 8, 2024 and was awarded on July 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,990.36, is for the delivery of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,242.70 firm fixed-price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024 and was awarded on August 6, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
- The U.S. government awarded a $3,248.76 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 1,500 units of KEDRAB 10 mL vials. This contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,500 units of the KEDRAB 10 ML vial. The $1,624.37 firm fixed-price delivery order has an ultimate completion date of November 21, 2024. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award is for the delivery of KEDRAB, a 1,500 unit/10 ml vial, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $1,624.37 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 2, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $4,863.90 firm-fixed-price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. The...
- This federal contract award, valued at $1,843.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, is for the provision of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The contract has an ultimate completion date of October 5, 2023 and is a firm fixed-price arrangement. Amerisourcebergen, which is registered in the System for Award Management (SAM.gov)...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of KEDRAB 150 U/ML VL 1S medical products to support the Defense Logistics Agency (DLA) Troop Support Medical. The $9,393.16 firm-fixed-price delivery order has a completion date of December 31, 2024. The award is under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for supplying a...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FP03ADelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,242.70 firm-fixed-price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, and has an ultimate completion date of May 10, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 4/19/24 |